ProShare Advisors’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,302
| Closed | -$10.3K | – | 2019 |
|
|
2023
Q4 | $10.3K | Buy |
1,302
+294
| +29% | +$2.32K | ﹤0.01% | 1942 |
|
|
2023
Q3 | $4.45K | Sell |
1,008
-1
| -0.1% | -$4 | ﹤0.01% | 1814 |
|
|
2023
Q2 | $35.1K | Buy |
1,009
+99
| +11% | +$3.44K | ﹤0.01% | 1801 |
|
|
2023
Q1 | $19.8K | Buy |
910
+148
| +19% | +$3.23K | ﹤0.01% | 1737 |
|
|
2022
Q4 | $16.5K | Buy |
762
+109
| +17% | +$2.36K | ﹤0.01% | 1814 |
|
|
2022
Q3 | $16K | Sell |
653
-12
| -2% | -$294 | ﹤0.01% | 1721 |
|
|
2022
Q2 | $13K | Sell |
665
-403
| -38% | -$7.88K | ﹤0.01% | 1782 |
|
|
2022
Q1 | $38K | Buy |
1,068
+95
| +10% | +$3.38K | ﹤0.01% | 2131 |
|
|
2021
Q4 | $26K | Buy |
973
+402
| +70% | +$10.7K | ﹤0.01% | 2321 |
|
|
2021
Q3 | $25K | Sell |
571
-565
| -50% | -$24.7K | ﹤0.01% | 1995 |
|
|
2021
Q2 | $57K | Buy |
+1,136
| New | +$57K | ﹤0.01% | 2350 |
|